Proctoform: Product Information and Clinical Use
Proctoform (also marketed as Proctofoam) is a topical hemorrhoidal foam containing pramoxine hydrochloride 1% as a local anesthetic, indicated for temporary relief of pain and itching associated with hemorrhoids. 1
What is Proctoform?
Proctoform is an over-the-counter, non-steroidal topical preparation delivered as an aerosol foam. The active ingredient, pramoxine hydrochloride (1%), provides local anesthetic effects to relieve hemorrhoidal symptoms. A prescription-strength version (Proctofoam-HC) combines pramoxine with hydrocortisone for enhanced anti-inflammatory effects.
Indications
- Temporary relief of pain and itching associated with hemorrhoids 1
- Particularly useful for perianal skin irritation due to poor hygiene, mucus discharge, or fecal seepage in patients with first-degree hemorrhoids 2
The American Gastroenterological Association guidelines support topical corticosteroids and analgesics for managing perianal symptoms, though they note that data supporting over-the-counter topical agents are lacking 3. Topical analgesics may provide symptomatic relief of local pain and itching, but do not reduce hemorrhoidal swelling, bleeding, or protrusion 3.
Dosage and Administration
Adults:
- Shake well before use
- Cleanse affected area with mild soap and warm water when practical; rinse thoroughly and gently dry
- Dispense foam onto clean tissue and apply externally to affected area up to 5 times daily
- Store upright at controlled room temperature (20-25°C/68-77°F)
- Do not refrigerate 1
Children under 12 years: Consult a physician 1
Critical Administration Instructions
Do NOT:
- Insert into the rectum using fingers or any mechanical device/applicator
- Exceed recommended daily dosage unless directed by physician
- Store above 49°C (120°F) or puncture/burn the aerosol container 1
Contraindications and Warnings
Stop use and consult a physician if:
- Rectal bleeding occurs
- Condition worsens or does not improve within 7 days
- Allergic reaction develops
- Redness, irritation, swelling, pain, or other symptoms develop or increase 1
Special Populations:
- Pregnancy/Breastfeeding: Ask healthcare professional before use 1. However, research demonstrates that Proctofoam-HC is safe for use in late pregnancy, with no adverse fetal effects on birth weight, gestational age, or rates of prematurity 4, and provides effective symptom relief 5.
Important Caveat: The AGA guidelines emphasize that prolonged use of potent corticosteroid preparations may be harmful and should be avoided 2. This applies to the prescription Proctofoam-HC formulation, not the non-steroidal version.
Clinical Context and Limitations
Role in Hemorrhoid Treatment Algorithm
According to AGA guidelines, medical therapy is most appropriate for first-degree hemorrhoids (bleeding without prolapse). The cornerstone remains adequate fiber and water intake 2. Topical agents like Proctoform serve as adjunctive symptomatic relief but do not address the underlying pathology.
Treatment escalation:
- First-degree: Fiber/water + topical agents (if needed)
- Second/third-degree: Nonoperative ablative techniques (rubber band ligation preferred for efficacy despite more discomfort) 2, 3
- Fourth-degree or failed conservative therapy: Hemorrhoidectomy 2
Key Clinical Pitfalls
- Do not assume hemorrhoids without proper examination - symptoms like bleeding, pain, and itching can indicate anal fissure, abscess, or fistula 2
- All rectal bleeding requires sigmoidoscopy - atypical bleeding patterns warrant full colonoscopy 2
- Topical agents do not reduce hemorrhoidal tissue - they only provide symptomatic relief 3
- Immunocompromised patients are at increased risk for severe infection after interventional procedures 2
The evidence supporting topical hemorrhoidal preparations remains limited, but Proctoform provides a reasonable option for symptomatic management when used appropriately as part of comprehensive hemorrhoid care that prioritizes fiber supplementation and addresses underlying causes.